All Curated Mutation Sites in EBV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

EBNA-3B/EBNA-3C

Keyword: Hodgkin Disease-17854036

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	17854036	30_bp del	LMP-1	LMP-1	Hodgkin Disease	R L	View
2	17854036	Q322K	LMP-1	LMP-1	Hodgkin Disease	R L	View
3	17854036	Q322N	LMP-1	LMP-1	Hodgkin Disease	R L	View
4	17854036	E328Q	LMP-1	LMP-1	Hodgkin Disease	R L	View
5	17854036	S309N	LMP-1	LMP-1	Hodgkin Disease	R L	View
6	17854036	L338S	LMP-1	LMP-1	Hodgkin Disease	R L	View
7	17854036	Q334R	LMP-1	LMP-1	Hodgkin Disease	R L	View
8	17854036	D293G	LMP-1	LMP-1	Hodgkin Disease	R L	View
9	17854036	Q322E	LMP-1	LMP-1	Hodgkin Disease	R L	View
10	17854036	H352R	LMP-1	LMP-1	Hodgkin Disease	R L	View
11	17854036	G252A	LMP-1	LMP-1	Hodgkin Disease	R L	View
12	17854036	N273S	LMP-1	LMP-1	Hodgkin Disease	R L	View
13	17854036	D233N	LMP-1	LMP-1	Hodgkin Disease	R L	View
14	17854036	D282G	LMP-1	LMP-1	Hodgkin Disease	R L	View
15	17854036	G353D	LMP-1	LMP-1	Hodgkin Disease	R L	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.